Targeting cysteine residues outside the ATP‐binding cassette of CDK7 is a novel approach for developing CDK7is,22 enabling selective repression of CDK7 kinase activity, RNAPOLII CTD phosphorylation, SE activity and gene transcription, culminating in cancer cell death.22, 23, 24. This evidence concerns the gene CDK7 and cancer.